GLP-1 Peptide Therapy in the UK: What It Is and What It Isn't (October 2026)

01 · The core answer

Is GLP-1 a peptide therapy?

Yes, in the plain scientific sense. GLP-1 stands for glucagon-like peptide-1, a hormone released by the gut after eating, and the medicines in this class are designed to act on the same receptor. That is where the phrase "GLP-1 peptide therapy" comes from.

The trouble is that "peptide therapy" is also used loosely online. It can describe anything from a licensed prescription pen to powders sold as "research chemicals". Those are not the same thing, and the difference matters for your safety.

A licensed GLP-1 medicine has a UK product licence, a defined dose ladder, a patient information leaflet and a regulated supply chain. A research peptide has none of these.

02 · Decision

Licensed treatment or unlicensed peptide: which are you looking at?

Use this table to sort what you are being offered. If it falls in the right-hand column, treat it as a warning sign.

Mounjaro must not be combined with other GLP-1 medicines, unlicensed "research" peptides (such as retatrutide, which has no UK licence), or compounded copies. These combinations have no safety data and no regulated supply chain.¹ If something promises faster results outside a licensed pathway, that is the warning sign.

03 · Next step

What should you do next?

If you are researching treatment for weight management, the sensible next step is a prescriber conversation rather than a peptide purchase. You can check whether you are likely to be suitable through our weight loss clinic, where a free online consultation is reviewed by a GPhC-registered prescriber. For wider costs, see our GLP-1 therapy cost information.

Related guide: Glp 1 peptide prescription requirements regulations.

04 · How GLP-1 therapy works

How GLP-1 therapy works

GLP-1 therapy works by acting on the gut-hormone system that helps regulate appetite. Tirzepatide, the active ingredient in Mounjaro, is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ The medicine is a tool that makes the diet easier to follow. It does not replace the diet or physical activity.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ For a broader overview of the class, see our page on GLP-1 receptor agonist therapy.

05 · Is it the same as Ozempic?

Is GLP-1 peptide the same as Ozempic?

No. GLP-1 is the name of a hormone and a drug class. Ozempic and Wegovy are brand names of semaglutide, which is one medicine within that class. Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. Mounjaro is tirzepatide, a different medicine.

Semaglutide is a single-action GLP-1 medicine, whereas tirzepatide activates both GIP and GLP-1 receptors.¹

So when someone says "GLP-1 peptide", ask which medicine they mean. The brand, the dose ladder and the licence all differ. If you are weighing two options, our Wegovy pen page sets out the other main licensed injectable.

06 · What results to expect

Is GLP-1 peptide therapy good for weight loss?

Licensed GLP-1 treatment has been shown to produce meaningful weight loss in trials, but averages are not predictions. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Most people ask how much they can lose in a few months. The trial reports results over a long period and each person responds differently. Dose, adherence, diet, activity and your starting point all play a part. Your prescriber can set realistic expectations once they know your history.

The trial also looked at how many people reached particular milestones. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

07 · Who should be cautious

Who should not take GLP-1 peptides?

Whether you should take a GLP-1 medicine is a decision for a prescriber, based on your health history, medicines and goals. Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.¹¹³

Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. A prescriber will also ask about your weight-related health, other conditions and current medicines. Be complete and honest in the consultation. It is the main safety step.

Anyone sold "peptides" without a consultation or prescription has skipped that step. That alone is a reason to walk away.

If you notice a new symptom after starting treatment, tell your prescriber. You can also report suspected side effects through the MHRA Yellow Card scheme.¹⁹

08 · Downsides and side effects

What is the downside to taking GLP-1?

Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹¹³

Other practical downsides are worth weighing honestly. Treatment is not a one-off: it works alongside a reduced-calorie diet and increased physical activity. It involves a regular injection. It has a cost if you are paying privately, and the NHS route is still being phased in. Our cost guide covers that side.

Also bear in mind that stopping treatment is not instant to reverse. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

If a side effect worries you, speak to your prescriber rather than adjusting the dose yourself. Ongoing monthly reviews with our prescribing team are included for exactly this reason.

09 · Food and eating questions

What foods should you avoid on GLP-1 treatment?

No food is banned on Mounjaro. Treatment is used alongside a reduced-calorie diet and increased physical activity.¹

Because the medicine slows how quickly the stomach empties, many people find they feel full sooner and less hungry between meals.¹ Practical eating habits that follow from this are common sense rather than rules: smaller portions, eating slowly, and noticing fullness early. If particular foods leave you uncomfortable, note them and discuss them with your prescriber or a dietitian.

Can you eat fruit?

No food is banned on Mounjaro, and fruit is not singled out as something to avoid. Fruit can sit comfortably within a reduced-calorie diet, but your prescriber or a registered dietitian can tailor advice to your health conditions.

What foods should you drop to lose weight?

There is no universal short list. A sustainable reduced-calorie diet is built around your preferences and health needs, not around three banned foods. Be wary of any seller who claims a single food swap or supplement does the work of a licensed medicine.

10 · Regulation and supply

Prescription rules and safe supply

In the UK, GLP-1 injectables for weight management are prescription-only medicines. They should only be supplied by a registered pharmacy after a consultation with a prescriber. You can verify any UK pharmacy on the GPhC register; ours is GPhC 9012878.¹²

The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected side effects or fake products.⁷ Genuine pens come from a regulated chain. Our Mounjaro is supplied through official LillyDirect supply, sourced directly from Eli Lilly's UK distribution, as genuine KwikPens.

For the injection format specifically, see GLP-1 peptide injections.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

12 · NHS or private?

NHS or private access

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Ask your GP what is available locally. If you go private, the safe route is the same as on the NHS: a prescriber review, a licensed medicine and a regulated pharmacy. Delivery from us is free, next-day, tracked and temperature-controlled, with same-day dispatch when ordered by 3pm.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.